Minnesota Medicaid Incentives to Prevent Chronic Disease
MMIPCD
2 other identifiers
interventional
1,500
1 country
1
Brief Summary
The objective of this study is to test whether two different participant financial incentive structures are more effective and cost effective than minimal financial incentives in increasing weight loss among Minnesota Medicaid beneficiaries at high risk of developing diabetes. The incentives are tied to participation and weight loss in the evidence-based group-delivered YMCA diabetes prevention program (Y-DPP). The Investigators will conduct a group randomized trial that includes up to 150 Y-DPP classes of 10-15 participants per class for up to 1500 Medicaid beneficiaries participating in the Y-DPP classes. This approach, if successful, will (a) improve weight loss. diabetes risk, and improve cardiovascular risk among Medicaid beneficiaries at risk for developing diabetes and other chronic conditions, (b) demonstrate that prevention of chronic disease risk factors using patient incentives is cost-effective, and (c) provide a patient incentive model that can be widely used among Medicaid beneficiaries at risk for developing diabetes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2013
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 16, 2015
CompletedFirst Posted
Study publicly available on registry
April 21, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedOctober 18, 2016
March 1, 2016
3.5 years
April 16, 2015
October 14, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
DPP Attendance
Participation in DPP core and post-core sessions
12 months
Weight Change
Change in participants' weight
12 months
Study Arms (3)
Individual Incentive
EXPERIMENTALParticipants receive a financial incentive every time they attend a class session and goal-based incentives for attending 75% of Core sessions, 75% of Post-Core sessions, separately achieving 5%, 7%, and 10% weight loss during the Core period (i.e. separate financial incentives for each goal reached at any point during the Core period), and 5%, 7%, or 10% weight loss by the end of Post-Core Session 8 (i.e., one financial incentive based on final weight loss).
Group Incentive
EXPERIMENTALThis arm receives the same routine attendance incentives as the Individual Incentive arm. Group goal-based incentives include 5% weight loss by an individual during the Core period and, separately, during the Post-Core period. Financial incentives are also received if the entire DPP group achieves 75% Core session attendance, 75% of Post-Core session attendance, 7% or 10% weight loss from baseline during the Core, and 7% or 10% weight loss from baseline at the end of the Post-Core period.
Minimal Incentive
OTHERParticipants receive the full Diabetes Prevention Program (DPP), but receive a nominal $25 financial incentive for attendance only at the first DPP session and no other incentives for attendance or weight loss.
Interventions
Use of financial incentives to promote health behaviors.
Eligibility Criteria
You may qualify if:
- currently enrolled in Medical Assistance, PMAP, or MinnesotaCare (collectively referred to as Medicaid)
- years of age
- body mass index ≥ 25 kg/m2 (≥ 22 kg/m2 for those of Asian descent)
- have prediabetes or a history of gestational diabetes mellitus (GDM)
You may not qualify if:
- diagnosis of diabetes
- pregnant at the time of enrollment
- planning gastric bypass surgery within the next 12 months
- diagnosed with Alzheimer's disease (ICD-9 331.0) or dementia (ICD-9 290.0 - 294.9)
- provider judgment regarding suitability for the study based on substance abuse, uncontrolled mental illness, or other conditions that may affect the participants health or ability to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Minnesota Department of Human Serviceslead
- Minnesota Department of Healthcollaborator
- HealthPartners Institutecollaborator
Study Sites (1)
Minnesota Department of Health
Saint Paul, Minnesota, 55164-0882, United States
Related Publications (1)
Desai JR, Vazquez-Benitez G, Taylor G, Johnson S, Anderson J, Garrett JE, Gilmer T, Vue-Her H, Rinn S, Engel K, Schiff J, O'Connor PJ. The effects of financial incentives on diabetes prevention program attendance and weight loss among low-income patients: the We Can Prevent Diabetes cluster-randomized controlled trial. BMC Public Health. 2020 Oct 21;20(1):1587. doi: 10.1186/s12889-020-09683-5.
PMID: 33087083DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gretchen Taylor
Minnesota Department of Health
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 16, 2015
First Posted
April 21, 2015
Study Start
March 1, 2013
Primary Completion
September 1, 2016
Study Completion
September 1, 2016
Last Updated
October 18, 2016
Record last verified: 2016-03